OcuTerra Therapeutics

Biotechnology, Therapeutics
Founded in 1/1/11
Boston, Massachusetts, United States
http://www.ocuterratx.com/
For Profit

About OcuTerra Therapeutics

OcuTerra Therapeutics, Inc. is developing innovative drugs for ophthalmic diseases for which the current standard of care does not prevent or control the progression of the disease.

Company Metrics

  • Employees: 11-50
  • Monthly Visits: None
  • Tech Stack: None active products

Financial Information

  • Estimated Revenue:
  • Total Funding: 35000000 USD
  • Last Funding: 35000000 USD (Series B)
  • Funding Status: Early Stage Venture

Technology Stack

OcuTerra Therapeutics actively uses None products in their tech stack.

Market Presence

Industries: Biotechnology, Therapeutics

Headquarters: Boston, Massachusetts, United States

Leadership

  • David Tanzer - Chief Medical Officer | Executive Vice President - Clinical and Medical Affairs LinkedIn

Employees

  • Kerrie Brady - Chief Executive Officer (LinkedIn)